Valuation: PharmaEssentia Corporation

Market Cap 493B 15.53B 13.86B 12.91B 11.75B 22.13B 1,496B 22.29B 156B 60.69B 764B 58.31B 57.06B 2,454B P/E 2026 *
44x
P/E 2027 * 27.7x
Enterprise Value 467B 14.71B 13.12B 12.23B 11.13B 20.95B 1,417B 21.11B 148B 57.48B 723B 55.22B 54.03B 2,324B EV / Sales 2026 *
16.3x
EV / Sales 2027 * 11.1x
Free-Float
79.23%
Yield 2026 *
0.34%
Yield 2027 * 0.2%
1 day+2.15%
1 week+3.03%
Current month-2.06%
1 month-9.16%
3 months-5.37%
6 months+108.87%
Current year+180.86%
1 week 1,140
Extreme 1140
1,240
1 month 1,125
Extreme 1125
1,450
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 56.05
Extreme 56.051993
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 2016-12-31
Director of Finance/CFO - 2015-10-13
President - 2015-06-24
Director TitleAgeSince
Director/Board Member 73 2024-04-30
Director/Board Member - 2021-08-04
Director/Board Member - 2024-05-26
Change 5-day change 1-year change 3-year change Capi.($)
+2.15%+3.03%+136.14%+365.04% 15.16B
+4.16%+3.04%+49.37%+94.17% 74.16B
-0.37%-3.81%+19.51%+78.12% 57.39B
+1.63%-1.61%+3.16%+36.89% 47.64B
+0.64%+3.33%+347.53%+725.26% 44.29B
+2.22%-2.69%+28.62%+33.30% 42.5B
+0.87%-1.79%+4.62%+111.19% 40.71B
-0.54%+2.93%+9.31%+54.06% 30.97B
+1.56%+4.53%+31.34%+26.92% 28.53B
+1.26%-1.36%-7.07%-11.03% 24.34B
Average +1.32%-0.57%+62.25%+151.39% 40.57B
Weighted average by Cap. +1.48%-0.82%+61.13%+145.42%

Financials

2026 *2027 *
Net sales 28.58B 900M 803M 748M 681M 1.28B 86.71B 1.29B 9.04B 3.52B 44.26B 3.38B 3.31B 142B 41.51B 1.31B 1.17B 1.09B 989M 1.86B 126B 1.88B 13.13B 5.11B 64.27B 4.91B 4.8B 207B
Net income 10.93B 344M 307M 286M 260M 490M 33.15B 494M 3.46B 1.34B 16.92B 1.29B 1.26B 54.38B 18.25B 575M 513M 478M 435M 819M 55.36B 825M 5.77B 2.25B 28.26B 2.16B 2.11B 90.82B
Net Debt -26.15B -824M -735M -684M -623M -1.17B -79.31B -1.18B -8.27B -3.22B -40.48B -3.09B -3.02B -130B -34.24B -1.08B -962M -896M -816M -1.54B -104B -1.55B -10.83B -4.21B -53.02B -4.05B -3.96B -170B
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
26-10-04 NT$1,190.00 +2.15% 1,593,815
26-10-02 NT$1,165.00 -0.43% 1,255,233
26-10-01 NT$1,170.00 -3.70% 2,506,975
26-09-30 NT$1,215.00 +1.67% 1,685,359
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,190.00TWD
Average target price
1,482.61TWD
Spread / Average Target
+24.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock